Chilton Capital Management LLC Gilead Sciences, Inc. Transaction History

Chilton Capital Management LLC

$2.34 Billion
Q3 2024

A detailed history of Chilton Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Chilton Capital Management LLC holds 185 shares of GILD stock, worth $16,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185

Previous 165 12.12%

Holding current value

$16,685

Previous $11,000 36.36%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $1,331 - $1,679	20 Added 12.12%	185 $15,000
Q2 2024 Aug 01, 2024	SELL	$63.15 - $72.88 $184,524 - $212,955	-2,922 Reduced 94.66%	165 $11,000
Q4 2023 Jan 18, 2024	BUY	$73.27 - $83.09 $1,611 - $1,827	22 Added 0.72%	3,087 $250,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $18,485 - $20,167	-250 Reduced 7.54%	3,065 $229,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $314,651 - $358,485	-4,070 Reduced 55.11%	3,315 $275,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $12,562 - $14,350	-211 Reduced 2.78%	7,385 $456,000
Q2 2022 Aug 16, 2022	BUY	$57.72 - $65.01 $35,440 - $39,916	614 Added 8.79%	7,596 $470,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $11,584 - $14,516	200 Added 2.95%	6,982 $415,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $261,531 - $296,842	-4,031 Reduced 37.28%	6,782 $492,000
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $11,710 - $12,634	173 Added 1.63%	10,813 $755,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $8,885 - $9,709	140 Added 1.33%	10,640 $733,000
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $18,000 - $20,537	-300 Reduced 2.78%	10,500 $679,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $82,142 - $93,597	-1,450 Reduced 11.84%	10,800 $629,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $76,847 - $98,429	-1,227 Reduced 9.1%	12,250 $916,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $70,863 - $77,947	-1,150 Reduced 7.86%	13,477 $876,000
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $70,698 - $78,039	-1,131 Reduced 7.18%	14,627 $927,000
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $108,891 - $122,108	-1,760 Reduced 10.05%	15,758 $1.07 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $65,656 - $73,552	1,050 Added 6.38%	17,518 $1.14 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $33,599 - $43,845	555 Added 3.49%	16,468 $1.03 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $8,910 - $9,865	-125 Reduced 0.78%	15,913 $1.23 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $37,111 - $43,288	-572 Reduced 3.44%	16,038 $1.14 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $44,796 - $54,612	615 Added 3.84%	16,610 $1.25 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $14,941 - $17,539	-210 Reduced 1.3%	15,995 $1.15 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.17 Million - $1.39 Million	16,205	16,205 $1.31 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.

Account

Chilton Capital Management LLC Gilead Sciences, Inc. Transaction History